银屑病治疗药物Wynzora乳膏的治疗效果和注意事项概述

Introduction: Wynzora cream is a topical medication used to treat plaque psoriasis, also known as calcipotriene and betamethasone dipropionate cream, with high patient compliance and treatment convenience. This article mainly talks about the therapeutic effects, precautions, medication reference, etc. of Wynzora cream.

Treatment effect

1. Rapid onset of effect: After patients use Wynzora cream, the results usually take about 7 days. This is due to its unique formula, which makes it easily absorbed by the skin and has the advantage of rapid onset of action.

2. Significant efficacy: Clinical trials have proven that Wynzora cream can significantly improve the symptoms of psoriasis. In a clinical trial of 972 patients with psoriasis, the treatment group using Wynzora cream reduced the psoriasis severity score (PASI) by an average of 73.3% after 8 weeks, which was better than the treatment group using calcipotriol ointment alone.

3. Good tolerability and safety: Wynzora cream uses PAD™ technology, a new oil-in-water formula and delivery system, which keeps calcipotriol and betamethasone dipropionate stable. This technology enables the cream to have high permeability in target tissues, improve solubility and stability, thereby improving treatment efficiency and tolerability. At the same time, Wynzora cream has shown good safety and high convenience in phase III trials conducted in the United States and the European Union.

Precautions

Wynzora cream is applied once a day, usually for 8 weeks, but if symptoms improve earlier, treatment should be discontinued. Do not use more than 100 grams per week. Wynzora Cream is not intended for oral, ophthalmic, or vaginal use. May increase risk of cataracts and glaucoma, referral to an ophthalmologist should be considered if visual symptoms occur. Wynzora cream may cause eye irritation and contact with eyes should be avoided.

Sun exposure should be avoided during use as some ingredients in the cream may make the skin more susceptible to sun damage. If you must be exposed to the sun, apply sunscreen. Please use the medicine strictly according to the doctor's instructions, and adhere to the dosage and frequency of medication on the instructions. Do not increase the dosage or duration of use without authorization.

Medication Reference

Wynzora Cream is suitable for topical treatment of plaque psoriasis in patients aged 18 years and above. Cream form containing calcipotriol 0.005% and betamethasone dipropionate 0.064%. Apply Wynzora Cream to the affected area once daily. When plaque psoriasis is under control, patients should stop treatment. Do not use on the face, groin, or underarms, or if there is skin atrophy in the treatment area.

While effective in treating plaque psoriasis, it does not cure the disease. In addition, patients need to pay attention to some possible side effects when using it, such as hypercalcemia and hypercalciuria. If these side effects occur, stop taking the medication immediately and consult your doctor.